A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Institut Curie
National Cancer Institute (NCI)
University of Washington
Palleos Healthcare GmbH
Wake Forest University Health Sciences
University of Southern California
Roswell Park Cancer Institute
UNICANCER
Indiana University
Inova Health Care Services
UNICANCER
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine
University of Washington
SOLTI Breast Cancer Research Group
Samsung Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gustave Roussy, Cancer Campus, Grand Paris
The Netherlands Cancer Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Washington
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
Mayo Clinic